Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Anogenital Distance to Determinate Fetal Gender Beetween 18 et 41 Weeks of Gestation.

NCT03898440 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03898440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03898440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Anogenital Distance to Determinate Fetal Gender Beetween 18 et 41 Weeks of Gestation.
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
April 15, 2019
Completion date
September 4, 2021
Enrollment
318 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prenatal disorder, sex development disorder, urogenital abnormalities